Evident Vascular Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$19M
- Investors
-
2
Evident Vascular General Information
Description
Developer of intravascular ultrasound (IVUS) technology intended to deliver improved image interpretation. The company features advanced AI algorithms that can automatically identify and segment key vascular structures for peripheral vascular image-guided therapy, providing clinicians with real-time insights and guidance to inform decision-making and improve patient care.
Contact Information
Website
www.evidentvascular.comCorporate Office
- 142 Charcot Avenue
- San Jose, CA 95131
- United States
Corporate Office
- 142 Charcot Avenue
- San Jose, CA 95131
- United States
Evident Vascular Timeline
Evident Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 25-Mar-2025 | $19M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 17-Oct-2023 | Completed | Generating Revenue |
Evident Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 37,500,000 | $0.000100 | 8% | $0.2 | $0.2 | 1x | $0.2 | 7.98% |
| Series A | 32,500,000 | $0.000100 | 8% | $0.2 | $0.2 | 1x | $0.2 | 8.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Evident Vascular Patents
Evident Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231837-A1 | Enhanced ultrasound blood flow visualization and imaging | Pending | 30-Apr-2025 | ||
| AU-2025255214-A1 | Electronic architecture for intravascular ultrasound technology | Pending | 11-Apr-2024 | ||
| WO-2025217396-A1 | Electronic architecture for intravascular ultrasound technology | Pending | 11-Apr-2024 | ||
| AU-2024366234-A1 | Systems and methods for enhanced ultrasound imaging | Pending | 27-Oct-2023 | ||
| EP-4798075-A1 | Systems and methods for enhanced ultrasound imaging | Pending | 27-Oct-2023 | A61B8/12 |
Evident Vascular Signals
Evident Vascular Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ShangBay Capital | Venture Capital | Minority | ||
| Vensana Capital | Venture Capital | Minority |
Evident Vascular FAQs
-
When was Evident Vascular founded?
Evident Vascular was founded in 2021.
-
Where is Evident Vascular headquartered?
Evident Vascular is headquartered in San Jose, CA.
-
What is the size of Evident Vascular?
Evident Vascular has 33 total employees.
-
What industry is Evident Vascular in?
Evident Vascular’s primary industry is Diagnostic Equipment.
-
Is Evident Vascular a private or public company?
Evident Vascular is a Private company.
-
What is the current valuation of Evident Vascular?
The current valuation of Evident Vascular is .
-
What is Evident Vascular’s current revenue?
The current revenue for Evident Vascular is .
-
How much funding has Evident Vascular raised over time?
Evident Vascular has raised $54M.
-
Who are Evident Vascular’s investors?
ShangBay Capital and Vensana Capital have invested in Evident Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process